EUVIMEDEUVIMED entdecken
Crossref

Ticagrelor vs. Clopidogrel Treatment in Chinese Patients with CKD After Percutaneous Coronary Intervention: Implications for East Asia

Yi-Lun Zhou, Akehu Alemasi

Journal of the American Society of Nephrology · 2026-10 · 37 (10S)

DOI: 10.1681/asn.2026d49p64ee ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026-10. Verfasst von Yi-Lun Zhou und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhou, Y., & Alemasi, A. (2026). Ticagrelor vs. Clopidogrel Treatment in Chinese Patients with CKD After Percutaneous Coronary Intervention: Implications for East Asia. Journal of the American Society of Nephrology, 37(10S). https://doi.org/10.1681/asn.2026d49p64ee

Vancouver

Zhou Y, Alemasi A. Ticagrelor vs. Clopidogrel Treatment in Chinese Patients with CKD After Percutaneous Coronary Intervention: Implications for East Asia. Journal of the American Society of Nephrology. 2026;37(10S). doi:10.1681/asn.2026d49p64ee

BibTeX
@article{Zhou2026,
  author = {Zhou, Yi-Lun and Alemasi, Akehu},
  title = {Ticagrelor vs. Clopidogrel Treatment in Chinese Patients with CKD After Percutaneous Coronary Intervention: Implications for East Asia},
  journal = {Journal of the American Society of Nephrology},
  year = {2026},
  volume = {37},
  number = {10S},
  doi = {10.1681/asn.2026d49p64ee}
}
Kostenlos starten →